Arquivamento definitivo - Art. 33 da LPI
#11.1.1
09/05/2023
RPI 2748
Application data
Number
112021017644Type
Filing
Publication
PCT
US2020021842 The application was abandoned: examination was not requested within the 36 months following the 03/10/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 09/05/2023. We update with every new RPI gazette, published weekly.
Applicants
BIOGEN MA INC.
US
Inventors
J. F. (pessoa física)
US
S. S. (pessoa física)
US
IPC Classification
Priority claims
US
62/816,668 · 03/11/2019
US
62/817,323 · 03/12/2019
Abstract
COMPOSIÇÕES FARMACÊUTICAS CONTENDO ANTICORPOS ANTI-LINGO-1. A presente invenção refere-se a composições farmacêuticas contendo anticorpos anti-LINGO-1 ou fragmentos de ligação à LINGO-1 dos mesmos. Essas composições farmacêuticas são utilizadas no tratamento de doenças desmielinizantes do SNC, tais como esclerose múltipla e neurite óptica (por exemplo, neurite óptica aguda).
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
09/05/2023
RPI 2748
#11.1
06/20/2023
RPI 2737
#1.3
11/16/2021
RPI 2654
#1.1
09/14/2021
RPI 2645
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.